Mithra
Stefan Leurs has extensive work experience in the pharmaceutical industry. Stefan currently holds the position of Head of CMC Development at Mithra since September 2021. Prior to this, they spent a significant portion of their career at Johnson & Johnson. From 2014 to 2021, they served as the Senior Director of Global Technical Services. Stefan also held various roles at the company, including Head Technical Integration Drug Product Development, Global CMC Team Leader, Department Head API Development, CMC Team Leader Early Development, and Head of Chemical Process Research. Before joining Johnson & Johnson, they worked as a Project Leader in API Development from 1995 to 1997.
Stefan Leurs completed their PhD in Chemistry with a specialization in organic synthesis from the University of Leuven between 1988 and 1992.
This person is not in any teams
This person is not in any offices
Mithra
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com